Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros











Intervalo de ano de publicação
1.
East Mediterr Health J ; 22(4): 258-66, 2016 Jul 10.
Artigo em Inglês | MEDLINE | ID: mdl-27432408

RESUMO

A socially accountable medical school is one that directs its education, research and service activities towards addressing the priority health concerns of the community it serves and verifying its impact on the community. This study aimed to assess the social accountability of the University of Gezira faculty of medicine in Sudan. We reviewed the literature, faculty documents and reports and used both the World Health Organization social accountability grid and the conceptualization-production-usability model as frameworks for analysis. In most of the domains and phases of the social accountability grid, the faculty's educational programme was found to be well-planned and well-implemented, demonstrating an impact on the community and active participation in health-system development in the local area. The University of Gezira faculty of medicine is socially responsible and responsive and is on the way to becoming fully socially accountable in certain aspects.


Assuntos
Docentes , Faculdades de Medicina , Responsabilidade Social , Currículo , Humanos , Estudos Retrospectivos , Sudão
2.
East. Mediterr. health j ; 22(4): 258-266, 2016-04.
Artigo em Inglês | WHO IRIS | ID: who-260321

RESUMO

A socially accountable medical school is one that directs its education, research and service activities towards addressing the priority health concerns of the community it serves and verifying its impact on the community. This study aimed to assess the social accountability of the University of Gezira faculty of medicine in Sudan. We reviewed the literature, faculty documents and reports and used both the World Health Organization social accountability grid and the conceptualization-production-usability model as frameworks for analysis. In most of the domains and phases of the social accountability grid, the faculty's educational programme was found to be well-planned and well-implemented, demonstrating an impact on the community and active participation in health-system development in the local area. The University of Gezira faculty of medicine is socially responsible and responsive and is on the way to becoming fully socially accountable in certain aspects


Un établissement d'enseignement médical socialement redevable est un établissement qui oriente son enseignement, sa recherche et les activités de ses services de façon à répondre aux préoccupations sanitaires prioritaires de la communauté qu'il sert et qui vérifie l'impact que cette démarche peut avoir à cet égard. La présente étude avait pour objectif d'évaluer la redevabilité sociale de la Faculté de médecine de l'Université de Gezira au Soudan. Nous avons examiné la littérature, les documents et les rapports de la faculté, et avons utilisé la grille de responsabilité sociale de l'Organisation mondiale de la Santé ainsi que le modèle de conception-production-utilisabilité comme cadres pour l'analyse. Dans la majorité des domaines et des phases de la grille de responsabilité sociale, le programme d'enseignement de la faculté s'est révélé être bien planifié et correctement mis en oeuvre, et a prouvé avoir un impact sur la communauté et sa participation active au développement des systèmes de santé à l'échelle locale. La Faculté de médecine de l'Université de Gezira est responsable et réactive sur le plan social, et est sur le point d'accéder à une pleine redevabilité sociale à certains égards


Assuntos
Responsabilidade Social , Organização Mundial da Saúde , Universidades , Faculdades de Medicina , Estudos Retrospectivos
3.
East Mediterr Health J ; 12(6): 783-91, 2006 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-17333823

RESUMO

We assessed the clinical and epidemiological features of severe malaria cases before admission, management in hospital and outcome and associated factors in 4 hospitals in different areas of Sudan over a 5-month period in 2000. There were 543 children admitted representing 21% of all paediatric admissions. Median age was 36 months. Treatment at home was the first action taken by 57.5% of families. Case fatality rate was 5/1000 and 93% of the children who died were under 9 years. Highest risk of death was associated with delay in seeking treatment and severity of illness before admission. Omdurman Hospital in Khartoum had the best case-management performance index compared to the other hospitals.


Assuntos
Criança Hospitalizada/estatística & dados numéricos , Malária Falciparum/epidemiologia , Malária Falciparum/terapia , Admissão do Paciente/estatística & dados numéricos , Distribuição por Idade , Administração de Caso/normas , Causas de Morte , Criança , Pré-Escolar , Estudos Transversais , Doenças Endêmicas/estatística & dados numéricos , Estudos Epidemiológicos , Feminino , Mortalidade Hospitalar , Hospitais de Distrito , Hospitais Pediátricos , Humanos , Lactente , Malária Cerebral/epidemiologia , Malária Cerebral/parasitologia , Malária Falciparum/complicações , Masculino , Avaliação de Resultados em Cuidados de Saúde , Pais/educação , Fatores de Risco , Estações do Ano , Índice de Gravidade de Doença , Sudão/epidemiologia
4.
(East. Mediterr. health j).
em Inglês | WHO IRIS | ID: who-117153

RESUMO

We assessed the clinical and epidemiological features of severe malaria cases before admission, management in hospital and outcome and associated factors in 4 hospitals in different areas of Sudan over a 5- month period in 2000. There were 543 children admitted representing 21% of all paediatric admissions. Median age was 36 months. Treatment at home was the first action taken by 57.5% of families. Case fatality rate was 5/1000 and 93% of the children who died were under 9 years. Highest risk of death was associated with delay in seeking treatment and severity of illness before admission. Omdurman Hospital in Khartoum had the best case- management performance index compared to the other hospitals


Assuntos
Malária , Avaliação de Resultados em Cuidados de Saúde
5.
East Afr Med J ; 79(4): 172-5, 2002 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-12625668

RESUMO

OBJECTIVES: To evaluate the efficacy of methyldopa in the treatment of mild pre-eclampsia, to prevent its progress and to investigate its effect on the pregnancy outcomes. DESIGNS: Randomised clinical trial. SETTING: Wad Medani Hospital in the central Sudan. SUBJECTS: Seventy primigravidae with single, alive baby of 28-36 weeks gestational age suffering from true mild pre-eclampsia were enrolled. The patients were randomised in two groups, treatment group who received methyldopa 750-4000 mg/day (n=34) and a control group who received no treatment (n=36). All the (treatment and control) patients were drug followed as in-patients till the delivery, seen with their babies on the days 7, 42 after the delivery. MAIN OUTCOMES MEASURES: The outcomes examined were, rise of the diastolic blood pressure to 110 mm Hg or more, occurrence of imminent eclampsia or the eclampsia, if the maturity could be achieved, occurrence of intrauterine growth retardation, abruptio placentae, mode of delivery, birth weight, placental weight, perinatal death, Apgar score and referral of the babies to the pediatrician. RESULTS: Three out of 34 (8.8%) of the treatment group had a rise in the diastolic blood pressure of 110 mm Hg, 18/36 (50%) of the control had a rise in the diastolic blood pressure of 110 mmHg (p < 0.05). Three out of thirty four (8.8%) of the treatment group developed imminent eclampsia, while 10/36 (27.8) of the control group developed imminent eclampsia (p < 0.05). The maturity was achieved in 82.3% and 88.8% of the treatment and the control, respectively (p > 0.05). There were ten (14.2%) perinatal deaths, four of them in the treatment group, while six in the control (p > 0.05). There was no difference regarding birth weight, occurrence of intrauterine growth retardation, placental weight, mode of delivery, Apgar score, referral of the babies to the paediatrician. No patient developed eclampsia or abruptio placenta; there was no maternal death in both groups. CONCLUSION: Methyldopa can prevent the progress of the mild pre-eclampsia to severe pre-eclampsia, without affecting the maturity, birthweight or the neonatal outcomes.


Assuntos
Anti-Hipertensivos/uso terapêutico , Metildopa/uso terapêutico , Pré-Eclâmpsia/tratamento farmacológico , Descolamento Prematuro da Placenta/etiologia , Adulto , Índice de Apgar , Peso ao Nascer , Parto Obstétrico/métodos , Progressão da Doença , Eclampsia/etiologia , Feminino , Morte Fetal/etiologia , Retardo do Crescimento Fetal/etiologia , Humanos , Tamanho do Órgão , Paridade , Pediatria/estatística & dados numéricos , Placenta/patologia , Pré-Eclâmpsia/classificação , Pré-Eclâmpsia/complicações , Gravidez , Resultado da Gravidez , Terceiro Trimestre da Gravidez , Encaminhamento e Consulta/estatística & dados numéricos , Índice de Gravidade de Doença , Resultado do Tratamento
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA